Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study

Bone Marrow Transplantation volume 29, pages 783–787 (2002)Cite this article

Abstract

We investigated whether daily oral washings with recombinant human granulocyte–macrophage colony-stimulating factor (rhGM-CSF) solution improved grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Forty-one consecutive patients (21 males and 20 females, median age (range) 44 (16–69) years) were prospectively randomized to perform daily mouth-washes with either a 400 μg rhGM- CSF (Molgramostin, Schering-Plough) solution (group A, n = 18) or with a saline solution (group B, n = 23). Primary end-points were the intensity of OM, night rest quality and characteristics of food intake. Secondary end-points were need for and duration of parenteral nutrition, oral and intravenous analgesic requirements, incidence of viral or fungal oral infections and development of neutropenic fever. No differences were found between the placebo and rhGM-CSF-treated groups regarding overall duration of OM, maximum grade, reduction in at least one grade of OM (nine patients (56%) in group A vs 13 patients (68%) in group B), reduction of spontaneous or swallowing-induced pain, improvement in oral food intake, use of parenteral nutrition or use of systemic analgesics. In conclusion, mouth-washings with a 400 μg of rhGM-CSF solution do not improve severe OM in hematological patients undergoing stem cell transplantation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Wardley AM, Jayson GC, Swindell R et al. Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haematopoietic progenitor rescue Br J Haematol 2000 110: 292 299

    Article  CAS  PubMed  Google Scholar 

  2. Pico JL, Avila-Garavito A, Nacacce P . Mucositis: Its occurrence, consequences, and treatment in the oncology setting The Oncologist 1998 3: 446 451

    CAS  PubMed  Google Scholar 

  3. Wilkes JD . Prevention and treatment of oral mucositis following cancer chemotherapy Semin Oncol 1998 25: 538 551

    CAS  PubMed  Google Scholar 

  4. Karthaus M, Rosenthal C, Ganser A . Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis – are there new strategies? Bone Marrow Transplant 1999 24: 1095 1108

    Article  CAS  PubMed  Google Scholar 

  5. Lieschke GJ, Ramenghi U, O'Connor MP et al. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation Br J Haematol 1992 82: 589 595

    Article  CAS  PubMed  Google Scholar 

  6. Katano M, Nakamura M, Matsuo T et al. Effect of granulocyte colony-stimulating factor on chemotherapy-induced oral mucositis Surg Today 1995 25: 202 206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Kannan V, Bapsy PP, Ananta N et al. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma Int J Radiat Oncol Biol Phys 1997 37: 1005 1010

    Article  CAS  PubMed  Google Scholar 

  8. Krawford J, Hozer H, Stoller R et al. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lungcancer New Engl J Med 1991 325: 164 170

    Article  Google Scholar 

  9. Nemunaitis J, Rosenfeld CS, Ash R et al. A phase III randomised, double-blind placebo-control trial of rhGM-CSF following allogeneic bone marrow transplantation Bone Marrow Transplant 1995 15: 949 954

    CAS  PubMed  Google Scholar 

  10. Legros M, Fleury J, Bay JO et al. RhGM-CSF vs placebo following rhGM-CSF mobilised PBPC transplantation: a phase III double-blind randomised trial Bone Marrow Transplant 1997 19: 209 213

    Article  CAS  PubMed  Google Scholar 

  11. Karthaus M, Rosenthal C, Huebner G et al. Effect of topical oral G-CSF on oral mucositis: a randomised placebo-controlled trial Bone Marrow Transplant 1998 22: 781 785

    Article  CAS  PubMed  Google Scholar 

  12. van der Lelie H, Thomas BLM, van Oers RHJ et al. Effect of locally applied GM-CSF on oral mucositis after stem cell transplantation: a prospective placebo-controlled double-blind study Ann Hematol 2001 80: 150 154

    Article  CAS  PubMed  Google Scholar 

  13. Miller AB, Hoogdtraten B, Staquet M, Winkler A . Reporting results in cancer patients Cancer 1981 47: 207 214

    Article  CAS  PubMed  Google Scholar 

  14. Rosso M, Blasi G, Gherlone E et al. Effect of granulocyte–macrophage colony-stimulating factor on prevention of mucositis in head and neck cancer patients treated with chemo-radiotherapy J Chemotherapy 1997 9: 382 385

    Article  CAS  Google Scholar 

  15. Nicolatou O, Sotiropoulou-Lontou A, Skarlatos J et al. A pilot study of the effect of granulocyte–macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X-radiation therapy: a preliminary report J Radiat Oncol Biol Phys 1998 42: 551 556

    Article  CAS  Google Scholar 

  16. Cartee L, Petros WP, Rosner GL et al. Evaluation of GM-CSF mouthwash for prevention of chemotherapy induced mucositis: a randomized double-blind dose-ranging study Cytokine 1995 7: 471 477

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Schering-Plough for kindly supplying the rhGM-CSF. We are indebted to the nursing staff of the Clinical Hematology Unit of the Hospital de la Santa Creu i Sant Pau for their clinical assistance.

Author information

Author notes

  1. D Valcárcel and MA Sanz: Both authors have equally contributed to the development of this work.

Authors and Affiliations

  1. Clinical Hematology Division, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    D Valcárcel, MA Sanz Jr, A Sureda, L Muñoz, M Subirá, R Laborda & J Sierra

  2. Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

    M Sala & A Clopés

Authors
  1. D Valcárcel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MA Sanz Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Sureda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Sala
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Muñoz
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Subirá
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Laborda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Clopés
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J Sierra
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Valcárcel, D., Sanz, M., Sureda, A. et al. Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study. Bone Marrow Transplant 29, 783–787 (2002). https://doi.org/10.1038/sj.bmt.1703543

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703543

Keywords

This article is cited by

Search

Advanced search

Quick links